Clinical Trials Logo

Atherosclerosis Obliterans clinical trials

View clinical trials related to Atherosclerosis Obliterans.

Filter by:
  • None
  • Page 1

NCT ID: NCT05473884 Recruiting - In-stent Restenosis Clinical Trials

Lesion Preparation in Femoropopliteal Artery Occlusion Disease

CIVILIAN
Start date: June 1, 2022
Phase:
Study type: Observational [Patient Registry]

Peripheral arterial disease (PAD) carries a significant global health burden, and can limit functional capacity and quality of life. Percutaneous transluminal angioplasty (PTA) for PAD is often associated with suboptimal outcomes due to complications following balloon inflation related to vessel trauma and flow limiting dissections that may require bailout stenting. Different strategies and techniques to enhance both acute and longer-term outcomes with drug-coated balloons (DCB) are needed. This is a national, prospective, multi-center, non-randomized, real-world study to evaluate the safety and efficacy of multiple vessel preparation strategies combined with drug-coating balloon (DCB) in Femoropopliteal Artery (F-PA) lesions.

NCT ID: NCT04440072 Recruiting - Clinical trials for Peripheral Arterial Disease

Comparison of 3 Ultrasonic Techniques for Measuring the Systolic Pressure Index

ABIPULSE
Start date: July 17, 2020
Phase:
Study type: Observational

Continuous Doppler ankle brachial index (ABI) is the gold standard for screening and monitoring of peripheral arterial disease (PAD) but is no longer carried out in clinical practice. The recommended measurement was gradually replaced by colour or pulsed Doppler without validation of these techniques. The objective of our study is to compare these two techniques (color Doppler and pulsed Doppler in echodoppler) with respect to the gold standard (continuous Doppler) for ABI measurement.

NCT ID: NCT03020290 Completed - Clinical trials for Atherosclerosis Obliterans

Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents

STELLASUPERA
Start date: December 2016
Phase:
Study type: Observational

Endovascular treatment with stenting is currently used in the treatment of femoro-popliteal lesions. This technique tends to extend to lesions for which the gold standard remains until now the open surgery treatment (lesions TASC C and D). The primary objective of the study was to evaluate the clinical efficacy at 12 months of the SuperA stent (Abbott) in the treatment of long de novo atherosclerotic lesions TASC C and D in patients with symptomatic peripheral arterial disease. The secondary objectives are to evaluate the clinical effectiveness of the SuperA stent at 24 months, according to clinical, morphological and haemodynamic criteria, the possible influence of calcifications and the quality of life of patients. The SuperA stent treatment is not specifically provided for by the Protocol but is carried out within the framework of the care. This study is an observationnal study.

NCT ID: NCT02501018 Completed - Clinical trials for Critical Limb Ischemia

Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI)

Start date: November 1, 2017
Phase: Phase 2
Study type: Interventional

A prospective, open label, controlled, randomized, double arm, multi-center study to assess the efficacy and safety of CLBS12 in patients with critical limb ischemia (CLI) due to arteriosclerosis obliterans (ASO) with a single arm sub-study to assess the safety and potential efficacy of CLBS12 in patients with CLI due to Buerger's Disease (BD).